Abstract
From studies of non-organ specific autoimmune diseases such as Lupus Erythematosus the concept has developed that autoimmunity is characterized by marked variation over time reflected by clinical remission and exacerbation. Our family studies of the development of Type I diabetes is providing us with a very different picture of the autoimmunity associated with Type I diabetes. In addition studies of NOD mice indicate that the Mendelian inheritance of a series of necessary but not sufficient diabetes associated alleles (H-2 NOD, theta linked, and the autosomal recessive gene determining anti-polar antibodies) create diabetes susceptibility. We will review our studies indicating that Type I diabetes is an autoimmune process in which there is remarkable quantitative stability of autoantibody levels amongst prediabetics (at times extending to more than a decade).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appel MC, O’Neil JJ, Wicker LB, Kurnick JT (1988) Both the Lyt2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140: 52–58
Baekkeskov S, Landan M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, Beaufort C, Soeldner JS, Eisenbarth GS, Lindgren F, Sundquist G, Lernmark A (1987) Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin dependent diabetes. J Clin Invest 79: 926–934
Bonifacio E, Dawkins RL, Lernmark A (1987) Immunology and diabetes workshops: report of the second international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 30: 273
Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL, Bach JF (1988) Factors associated with early remission of Type I diabetes in children treated with cyclosporine. N Engl J Med 318: 663–670
Buse JB, Ben-Nun A, Klein KA, Eisenbarth GS, Seidman JG, Jackson RA (1984) Class I, II and III major histocompatibility complex gene polymorphisms in BB rats. Diabetologia 22: 77–79
Colle E, Guttmann RD, Seemayer T (1981) Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med 154: 1237–1242
Colle E, Guttmann RD, Fuks A, Seemayer TA, Prud’homme GJ (1986) Genetics of the spontaneous diabetic syndrome. Interaction of the MHC and non-MHC associated factors. Mol Biol Med 3(1):13–23
Colman PG, DiMario U, Rabizadeh A, Dotta F, Anastasi E, Eisenbarth GS (1988) A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk to develop diabetes and in insulin dependent diabetes at onset. J Autoimmunity 1: 109–117
Colman PG, Tautkus M, Rabizadeh A, Cahill C, Eisenbarth GS (1988) Assay for islet cell antibodies with rat pancreas and peroxidase protein A. Diabetes Care 11: 367–368.
Diaz J-L, Wilkin T (1987) Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36: 66–72
Dib SA, Vardi P, Bonner-Weir S, Eisenbarth GS (1988) Selective localization of Factor VIII. Antigenicity to endothelial cells and expression of class II antigens by normal human pancreatic ductal epithelium. Diabetes 37: 482–487.
Dotta F, Bonner-Weir S, Cahill C, Appel M, Nayak RC, Eisenbarth GS (1988) Immunoreactivity of islet tumor cells: a new diabetes associated antigen (“polar” antigen). Clin Res 36: 480A
Dotta F, Wicker L, Peterson L, Pressey A, Appel M, Eisenbarth GS (to be published) Inheritance of anti-“polar” antibodies in NOD mice: evidence for a single recessive gene. Diabetes
Foulis AK, Farquharson MA, Meager A (1987) Immunoreactive alpha-interferon in insulin-secreting beta cells in Type I diabetes mellitus. Lancet 1423–1427
Grenier DL, Handler ES, Nakano K, Mordes JP, Rossini AA (1986) Absence of the RT6 T cell subset in diabetes-prone BB/W rats. J Immunol 136: 148–151
Grenier DL, Mordes JP, Handler ES, Angelillo M, Makamura N, Rossini AA (1987) Depletion of RT6.1+ T lymphocytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J Exp Med 166 (2): 461–475
Hattori M, Buse JB, Jackson RA, Glimcher L, Makino S, Moriwaki K, Dorff M, Minami M, Kuzuya H, Imura H, Seidman JG, Eisenbarth GS (1986) The NOD mouse: recessive diabetogenic gene within the major histocompatibility complex. Science 231: 733–735
Hattori M, Ikegami H, Eisenbrth GS, Makino S (1987) “Thy-1” linked diabetogenic gene but no “MHC” linked gene causes the primary destruction of beta cells of the NOD mouse. Diabetes suppl 1:82A
Ikegami H, Jackson RA, Makino S, Satt DE, Eisenbarth GS, Hattori M (1986) Homozygosity for two genes (H-2: chromosome 17 and Thy-1: chromosome 9) linked to development of Type I diabetes of the NOD mouse. Clin Res 34: 683A
Jackson RA, Morris MA, Haynes BF, Eisenbarth GS (1982) Increased circulating Ia-antigen-bearing T cells in Type I diabetes mellitus. N Engl J Med 306: 785–788
Jackson RA, Vardi P, Herskowitz R, Soeldner JS, Eisenbarth GS (1988) Dual parameter linear model for prediction of onset of Type I diabetes in islet cell antibody positive relatives. Clin Res 36: 585A
Koevary S, Rossini A, Stoller W, Chick W (1983) Passive transfer of diabetes in the BB/W rat. Science 220: 727–728
Lipes MA, Fenton RG, Zhou LZ, Seidman JG, Eisenbarth GS (to be published) Autoimmunity occurs in transgenic T cell receptor (TCR) beta gene non-obese diabetic (NOD) mice. Clin Res
Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS (1985) “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 34:617–619
Nishimoto H, Kikutani H, Yamamura K, Kishimoto T (1987) Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432–434
Pipeleers DG, In’t Veld PA, Pipeleers-Marichal MA, Gepts W, Van De Winkel M (1987) Presence of pancreatic hormones in islet cells with MHC-class II antigen expression. Diabetes 36: 872–876
Prochazka M, Leiter ED, Serreze DV, Coleman DG (1987) Three recessive loci required for insulin dependent diabetes in nonobese diabetic mice. Science 237: 286–289
Prowse SJ, Nomikoa IN, Pratt PF, Lafferty KJ (1986) Islet allografts are destroyed by disease recurrence in diabetic NOD mice and BB rats. Diabetes 55: 243
Rabinowe SL, Eisenbarth GS (1984) Immunotherapy of Type I (insulin dependent) diabetes mellitus. In: Andreani D, DiMario U, Federlin KF, Heding LG (eds), Immunology in Diabetes. Kimpton Medical Publications, London p 171–175
Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA (1988) Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52: 773–782
Serreze DV, Leiter EH, Worthen SM, Shultz LD (1988) NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON) Fl mice. Diabetes 37: 252–255
Shar SC, Malone JI, Simpson NE (1989) A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 320: 550–554
Soeldner JS, Tuttleman M, Srikanta S, Ganda OP, Eisenbarth GS (1985) Insulin dependent diabetes mellitus and initiation of autoimmunity: islet cell autoantibodies, insulin autoantibodies and beta cell failure. N Engl J Med 313 (14): 893–894
Stiller CR, Laupacis A, Dupre J, Jenner MR, Keown PA, Rodger W, Wolfe BMJ (1983) Cyclosporine for treatment of early Type I diabetes: preliminary results. N Engl J Med 308: 1226–1227
Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Franco-Bottazzo G, Gale EAM (1988) Predicting insulin-dependent. Diabetes April 16: 845–850
Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin dependent diabetes mellitus. Nature 329: 599–604
Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Rabizadeh A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS (1987) Competitive insulin autoantibody RIA: prospective evaluation of subjects at high risk for development of Type I diabetes mellitus. Diabetes 36: 1286–1291
Vardi P, Ziegler AG, Matthews JH, Dib S, Keller RJ, Ricker AT, Wolfsdorf JI, Herskowitz RD, Rabizadeh A, Eisenbarth GS, Soeldner JS (1988) Concentration of insulin autoantibodies at onset of Type I diabetes: inverse log-linear correlation with age. Diabetes Care 11: 736–739
Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC (1987) Genetic control of diabetes and insulitis in the non-obese diabetic (NOD) mouse. J Exp Med 165(6):1639–1654
Wilkin T, Palmer J, Bonifacio E, Diaz JL, Kruse V (1987) First international workshop on the standardization of insulin autoantibodies. Diabetologia 30: 676–677
Ziegler AG, Vardi P, Ricker AT, Hattori M, Soeldner JS, Eisenbarth GS (1989) Radioassay determination of insulin autoantibodies in NOD mice: correlation with increased risk of progression to overt diabetes. Diabetes 38: 358–363
Ziegler AG, Vardi P, Gross DJ, Bonner-Weir S, Villa-Kamaroff L, Halban P, Ikegami H, Soeldner JS, Eisenbarth GS (to be published) Production of insulin antibodies by mice rejecting insulin transfected cells. J Autoimmunity
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Russo, E. et al. (1990). Type I Diabetes as a “Mendelian” and “Regulated” Immune Process. In: Demaine, A.G., Banga, JP., McGregor, A.M. (eds) The Molecular Biology of Autoimmune Disease. NATO ASI Series, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75133-2_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-75133-2_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75135-6
Online ISBN: 978-3-642-75133-2
eBook Packages: Springer Book Archive